Experiments were conducted to investigate the effect of activated T ce
lls on the blood-nerve barrier (BNB) in experimental allergic neuritis
(EAN). T cells reactive to the P-2 component of myelin (P-2 T cells)
and known to cause EAN were injected into the sciatic nerve of Lewis r
ats. Animals were then given daily intraperitonenal (i.p.) injections
of serum with known demyelinating activity (rabbit EAN serum) or contr
ol serum. Serial nerve conduction studies across the injected segment
were performed and nerves were removed at various stages for histology
. Focal conduction block and perivascular demyelination were evident i
n T cell injected nerves of animals treated with EAN serum. In animals
treated with control serum no conduction block was seen and only peri
vascular infiltrates without demyelination were present. Similar resul
ts were obtained with T cells reactive to non-neural antigens, althoug
h the effect was less marked. Systemically administered rabbit immunog
lobulin (Ig) was demonstrated within the endoneurium of P-2 T cell inj
ected nerves by immunofluorescence and the endoneurial blood vessels s
howed increased permeability to circulating horseradish peroxidase (HR
P). These findings demonstrate that activated T cells cause focal brea
kdown of the BNB, allowing circulating antimyelin antibody to enter th
e endoneurium with consequent focal demyelination. P-2 reactive EAN pr
oducing T cells do not cause significant demyelination when injected i
ntraneurally (i.n.) in the absence of circulating antimyelin antibody.
Intraneural injection of tumour necrosis factor alpha (TNF-alpha) yie
lded similar results, causing conduction block and perivascular demyel
ination in the presence of circulating antimyelin antibody but not in
control serum treated animals.